# Elicio Therapeutics, Inc.: Form 8-K, filed Jan 22, 2025

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: 8-K
- Filed: 2025-01-22
- Accepted by EDGAR: Jan 22, 2025, 07:33 ET
- Period: 2025-01-22
- Accession: 0001601485-25-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000006/angn-20250122.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000006/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000160148525000006/angn-20250122.htm

Filed Jan 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001601485-25-000006. Last ingested by Listed: Nov 14, 2026, 18:50 ET. No prices; not investment advice.
